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In practise, how do we take the right decision for the 
individual patient if the evidence cannot be provided? 
The patient needs a good doctor who pays attention to 
triggering factors that are often hidden. He listens to the 
patient, examines the patient and discovers the things 
that are hidden. He then makes a diagnosis and provides 
personalised care and support. The good doctor is scien-
tifically trained and permanently educated. He knows the 
important values but also the restrictions of the “evi-
dence” of the treatments. The good doctor is “self-learn-
ing,” constantly fed by his experiences with individual pa-
tients and capable of integrating these experiences. He is 
an empathic and systematic thinker. He instinctively 
knows how to get to the essence which lies buried under 
the multitude of triggering factors. He will offer his pa-
tient the care that is needed in his or her specific situation. 
Medicine is the art of patient care. Quoting Paul Klee: 
“Art does not reflect what is seen, rather it makes the hid-
den visible.”
Deep learning is what physicians have been doing for 
years [1]: integrating knowledge and intuition. Deep 
learning has become crucial in a new world, the world of 
artificial intelligence.
We are witnessing great innovations in healthcare that 
allow for the multitude of factors that exist and influence 
the course of diseases. These factors can be classified un-
der biological systems including genomics, epigenomics, 
transcriptomics and proteomics, under the medical sys-
tem with data from the medical record and furthermore, 
and under welfare with a multitude of data regarding life-
style, leisure activities, workload and health apps. Unfor-
tunately, all these data are fragmented among electronic 
patient records that cannot talk to each other or are hid-
den due to privacy regulations. It is important that this 
information is stored in well-structured personalised 
clouds for each patient. Healthcare will make great prog-
ress as a result of “big data analytics,” a digital process 
with “deep learning,” exploring connections between a 
large number of triggering factors in very large patient 
populations. This development requires ethical reflection 
guaranteeing privacy on the one hand and enabling col-
lective analyses on the other.
Relevant personal evidence will have to be provided 
for each patient on the basis of his or her individual char-
acteristics. It concerns new evidence per patient with re-
gard to multifactorial processes: personalised evidence in 
support of the good doctor. In the literature, this develop-
ment is specified as “computational medicine,” “preci-
sion medicine” and “P4 medicine: predictive, personal-
ized, preventive, participatory” [2]. 
As the skin is, quite literally, right at the surface, der-
matology in particular can play a leading role in this de-
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velopment. Skin imaging, subsequent pattern recognition 
by “machine-based learning” connected to systems biol-
ogy, systems medicine and information on welfare in a 
digital environment will create a new form of evidence-
based healthcare. On the one hand, the individual pa-
tient’s cloud will contribute to data collection and, on the 
other, it will provide collective evidence for answers to 
relevant questions of the individual patient reconciling 
multiple factors. 
Questions such as:
1 Is there a risk that this patient will develop severe 
symptoms of psoriasis?
2 Will this patient likely develop comorbidities and if so, 
which ones?
3 To what treatments can this patient be expected to re-
spond well?
4 Is this a patient who requires active and early interven-
tion to prevent cumulative damage to his or her health 
and welfare?
We are moving from reactive medicine towards proac-
tive medicine.
Key Message
Psoriasis is a multifactorial disease. The estimation of the 
course of the disease and the selection of treatments is dependent 
on a host of factors. Big data are needed in order to be able to in-
vestigate the predictive value of the different aspects in an indi-
vidual patient.
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